GlaxoSmithKline Loses Bid to End Zofran Lawsuits

Drug Industry Daily
A A
GlaxoSmithKline lost its bid to end multiple lawsuits against the company alleging that its anti-nausea drug Zofran (ondansetron) caused birth defects.

To View This Article:

Login

Subscribe To Drug Industry Daily